MARK YOUNG — Lobbyist Profile | Poliscope

MARK YOUNG

Reported covered position: N/A

Filings

Clients

Firms

Years active

1999–2010

Associated filing income

$3,202,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
FUTURES INDUSTRY ASSOCIATION	17	2005–2010
TEVA PHARMACEUTICALS USA	11	2007–2009
CHICAGO BOARD OF TRADE	10	1999–2004
PROMARK INVESTMENT ADVISORS, INC.	4	2010
MARKETAXESS	2	2010
KBA NORTH AMERICA INC	1	2001

Lobbying firms

Firm	Filings	Years
KIRKLAND & ELLIS LLP	46	1999–2010

Bills explicitly cited in this lobbyist’s assigned issues (3)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1038

Access to Life-Saving Medicine Act

Client: TEVA PHARMACEUTICALS USA · Firm: KIRKLAND & ELLIS LLP

Open original LDA filing ↗

Cited source text

Generic biologic drug pathway, H.R. 1038, "The Access to Lifesaving Medicine Act."

H.R. 1038

Access to Life-Saving Medicine Act

Client: TEVA PHARMACEUTICALS USA · Firm: KIRKLAND & ELLIS LLP

Open original LDA filing ↗

Cited source text

Generic biologic drug pathway, H.R. 1038, "The Access to Lifesaving Medicine Act."

Original LDA source filings (46)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

MARKETAXESS via KIRKLAND & ELLIS LLP

2010 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

New legislation on swap execution facilities.

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE

PROMARK INVESTMENT ADVISORS, INC. via KIRKLAND & ELLIS LLP

2010 · second_quarter · Q2

Firm income: $70,000Client expense: —

Source: Senate LDA

Show 42 more original filings

PROMARK INVESTMENT ADVISORS, INC. via KIRKLAND & ELLIS LLP

2010 · first_quarter · Q1

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Regulation of swap transactions.

Filing targets: Commodity Futures Trading Commission (CFTC), SENATE

PROMARK INVESTMENT ADVISORS, INC. via KIRKLAND & ELLIS LLP

2010 · first_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Regulation of swap transactions.

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2010 · first_quarter · Q1

Firm income: $65,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

PROMARK INVESTMENT ADVISORS, INC. via KIRKLAND & ELLIS LLP

2010 · second_quarter · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Regulation of swap transactions.

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2009 · fourth_quarter · Q4

Firm income: $110,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2009 · third_quarter · Q3

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2009 · third_quarter · Q3

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2009 · second_quarter · Q2

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2009 · second_quarter · Q2

Firm income: $40,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2009 · first_quarter · Q1

Firm income: $110,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2009 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2008 · fourth_quarter · Q4

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2008 · fourth_quarter · Q4

Firm income: $70,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation Financial Market Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2008 · third_quarter · Q3

Firm income: $7,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2008 · third_quarter · Q3

Firm income: $120,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

Energy Market and Speculation Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2008 · second_quarter · Q2

Firm income: $50,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

CFTC Reauthorization Legislation Energy Market and Speculation Legislation

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2008 · second_quarter · Q2

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2008 · first_quarter · 1A

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2008 · first_quarter · Q1

Firm income: $25,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

CFTC Reauthorization Legislation SRO Governance Rules

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2008 · first_quarter · Q1

Firm income: $10,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2007 · year_end · YY

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

CFTC Reauthorization Legislation SRO Governance Rules

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2007 · year_end · YY

Firm income: $60,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2007 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

PHA

Pharmacy

House and Senate legislation on biologic medicines.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2007 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

CFTC Reauthorization Legislation SRO Governance Rules Defining boards of trade located outside U.S.

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

TEVA PHARMACEUTICALS USA via KIRKLAND & ELLIS LLP

2007 · mid_year · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

PHA

Pharmacy

Generic biologic drug pathway, H.R. 1038, "The Access to Lifesaving Medicine Act."

HCR

Health Issues

Generic biologic drug pathway, H.R. 1038, "The Access to Lifesaving Medicine Act."

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2006 · year_end · YY

Firm income: $200,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

FIN

Financial Institutions/Investments/Securities

S. 1566 introduced July 29, 2005, CFTC Reauthorization House Reauthorization Legislation SRO Governance Rules Defining located outside U.S.

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2006 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2005 · year_end · YA

Firm income: $240,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2005 · year_end · YA

Firm income: $240,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

FUTURES INDUSTRY ASSOCIATION via KIRKLAND & ELLIS LLP

2005 · year_end · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2004 · year_end · YT

Firm income: $0Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2004 · mid_year · MM

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2003 · year_end · YY

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2003 · mid_year · MA

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2003 · mid_year · MM

Firm income: $80,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

NATL STEEL CAR LTD via KIRKLAND & ELLIS LLP

2003 · mid_year · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2002 · year_end · YY

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2002 · mid_year · MM

Firm income: $20,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

KBA NORTH AMERICA INC via KIRKLAND & ELLIS LLP

2001 · year_end · RR

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

2000 · mid_year · MM

Firm income: $325,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

1999 · year_end · YY

Firm income: $300,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of

CHICAGO BOARD OF TRADE via KIRKLAND & ELLIS LLP

1999 · mid_year · MM

Firm income: $100,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (0 issues)

Filing targets: Commodity Futures Trading Commission (CFTC), Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of